» Authors » Jacques Darcourt

Jacques Darcourt

Explore the profile of Jacques Darcourt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 1336
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Le T, Comte V, Darcourt J, Razzouk-Cadet M, Rollet A, Orlhac F, et al.
Clin Nucl Med . 2024 Aug; 49(10):924-930. PMID: 39104036
Purpose: The aim of this study was to compare the performance and added clinical value of a semiautomated radiomics model and an automated 3-dimensinal convolutional neural network (3D-CNN) model for...
2.
Masse M, Chardin D, Tricarico P, Ferrari V, Martin N, Otto J, et al.
Eur J Nucl Med Mol Imaging . 2024 Jun; 51(12):3696-3708. PMID: 38896129
Aim: To determine the long-term prognosis of immune-related response profiles (pseudoprogression and dissociated response), not covered by conventional PERCIST criteria, in patients with non-small-cell lung cancer (NSCLC) treated with immune...
3.
Martin J, Pourcher T, Phan G, Guglielmi J, Crambes C, Caire-Maurisier F, et al.
Eur Thyroid J . 2024 Jan; PMID: 38241789
Background: Intake of potassium iodide (KI) reduces the accumulation of radioactive iodine in the thyroid gland in the event of possible contamination by radioactive iodine released from a nuclear facility....
4.
El Ouartassi A, Giordana C, Schiazza A, Chardin D, Darcourt J
Brain Imaging Behav . 2023 Jul; 17(6):619-627. PMID: 37474673
Purpose: First, to investigate the patterns of [F]-FDOPA positron emission tomography imaging in corticobasal syndrome using visual and semi-quantitative analysis and to compare them with patterns found in Parkinson's disease...
5.
Darcourt J, Chardin D, Bourg V, Gal J, Schiappa R, Blonski M, et al.
Eur J Nucl Med Mol Imaging . 2023 Apr; 50(9):2727-2735. PMID: 37086272
Background: Diagnostic value of 3,4-dihydroxy-6-[F]fluoro-L-phenylalanine ([F]FDOPA) PET in patients with suspected recurrent gliomas is recognised. We conducted a multicentre prospective study to assess its added value in the practical management...
6.
Comte V, Schmutz H, Chardin D, Orlhac F, Darcourt J, Humbert O
Eur J Nucl Med Mol Imaging . 2022 May; 49(11):3787-3796. PMID: 35567626
Purpose: FDOPA PET shows good performance for the diagnosis of striatal dopaminergic denervation, making it a valuable tool for the differential diagnosis of Parkinsonism. Textural features are image biomarkers that...
7.
Humbert O, Bauckneht M, Gal J, Paquet M, Chardin D, Rener D, et al.
Eur J Nucl Med Mol Imaging . 2022 May; 49(11):3878-3891. PMID: 35562529
Purpose: We evaluated the prognostic value of immunotherapy-induced organ inflammation observed on FDG PET in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs). Methods: Data...
8.
Verger A, Kas A, Darcourt J, Guedj E
Cancers (Basel) . 2022 Mar; 14(5). PMID: 35267411
PET plays an increasingly important role in the management of brain tumors. This review outlines currently available PET radiotracers and their respective indications. It specifically focuses on F-FDG, amino acid...
9.
Chardin D, Paquet M, Schiappa R, Darcourt J, Bailleux C, Poudenx M, et al.
J Immunother Cancer . 2020 Jul; 8(2). PMID: 32709713
Background: Reliable predictive and prognostic markers are still lacking for patients treated with programmed death receptor 1 (PD1) inhibitors for non-small cell lung cancer (NSCLC). The purpose of this study...
10.
Hoog C, Koulibaly P, Dejean C, Desdoits T, Humbert O, Barranger E, et al.
EJNMMI Phys . 2020 Jun; 7(1):37. PMID: 32504305
Purpose: Iodine-125 (I) seeds can be used as landmarks to locate non-palpable breast lesions instead of implanting metal wires. This relatively new technique requires a nuclear probe usually used for...